MIRACLL CHEMICALS CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.18 CNY | +2.44% |
|
+2.94% | +16.75% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.75% | 98Cr | - | ||
| +2.41% | 10TCr | A- | ||
| -11.02% | 5.98TCr | A- | ||
| +64.29% | 4.54TCr | B | ||
| +8.44% | 3.6TCr | B | ||
| +0.14% | 3.1TCr | A- | ||
| +5.72% | 1.9TCr | B- | ||
| +10.56% | 1.64TCr | C+ | ||
| +4.56% | 1.33TCr | B- | ||
| -5.80% | 1.29TCr | B |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 300848 Stock
- Ratings Miracll Chemicals Co.,Ltd
